Sign in to continue:

Thursday, July 30th, 2026

Mapletree Pan Asia Commercial Trust (MPACT) 2026 Analysis: Stable Singapore Growth Cushions Overseas Weakness – Buy Rating & Outlook

Broker: Maybank Research Pte Ltd
Date of Report: April 28, 2026

Excerpt from Maybank Research Pte Ltd report

Report Summary

Stock: Mapletree Pan Asia Comm. Trust (MPACT SP)
Recommendation: BUY
Target Price: SGD 1.50 (upside of +12%)
Share Price (at report): SGD 1.40

  • Key Idea: MPACT’s Singapore portfolio provides stability, offsetting continued weakness in overseas assets, particularly in Greater China and Japan.
  • Actionable Insight: Retain BUY on inexpensive valuations and improved balance sheet. The DDM-based target price is trimmed by 3% to SGD 1.50 due to mild overseas weakness.
  • Highlights:
    • 4Q DPU: SGD 1.90c (-2.6% YoY); FY26 DPU: SGD 7.97c (-0.6% YoY).
    • Occupancy stable at 89.4%; Singapore assets saw positive rental and NPI growth, while overseas assets continued to drag.
    • Cost of debt reduced to 3.16% with a further reduction to 3.0% guided; gearing improved to 36.5%.
    • Portfolio value fell 2.1%, mainly from overseas asset weakness; Singapore assets rose 3.1% in value.
    • FY27E/28E DPU guidance lowered by 0.2%/1.0% reflecting ongoing overseas weakness, partially offset by lower borrowing costs.
  • Implications: The report highlights the defensive nature of MPACT’s Singapore assets, lower cost of debt, and reasonable valuations as reasons to maintain a BUY call despite lower visibility in overseas assets. Investors are advised to focus on the stability and income profile provided by the Singapore portfolio.

above is an excerpt from a report by Maybank Research Pte Ltd. Clients of Maybank Research Pte Ltd can be the first to access the full report from the Maybank Research website : www.maybank-keresearch.com

TCL Electronics Holdings Ltd Poised for Strong Rebound: Bullish Momentum Ahead

Date of Report: October 24, 2024Broker: CGS InternationalOve...

Hong Leong Asia and several glove manufacturing stocks broke through key resistance levels

Yesterday, Hong Leong Asia and several glove manufacturing s...

Civmec trades at defensively low valuations of 7.9x forward P/E

Civmec Limited’s (S$0.94, unchanged) FY24 results came in-li...